Table 3.
Characteristics of trials that used an outcome measured with BMDs as a primary outcome (n = 75). Primary outcomes were those that were explicitly reported as such in the published article or in the entry in a public clinical trial registry or, if none was explicitly reported, the outcome(s) stated in the sample size estimation. All other outcomes were considered secondary outcomes
| Trials with at least one primary outcome measured with BMDs (n = 35) | Trials with no primary outcome measured with BMDs (n = 40) | |
|---|---|---|
| Number (%) of trials reporting the validity, reliability and responsiveness of the sensor | 8 (23) | 12 (30) |
| Number (%) of trials reporting adequate methods to manage missing outcome data | 19 (54) | 30 (75) |
| Number (%) of trials reporting information on incomplete BMD outcome data | 16 (46) | 8 (20) |